Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CLONAZEPAM Cause Therapeutic product ineffective? 38 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 38 reports of Therapeutic product ineffective have been filed in association with CLONAZEPAM (Clonazepam). This represents 0.1% of all adverse event reports for CLONAZEPAM.

38
Reports of Therapeutic product ineffective with CLONAZEPAM
0.1%
of all CLONAZEPAM reports
3
Deaths
25
Hospitalizations

How Dangerous Is Therapeutic product ineffective From CLONAZEPAM?

Of the 38 reports, 3 (7.9%) resulted in death, 25 (65.8%) required hospitalization, and 21 (55.3%) were considered life-threatening.

Is Therapeutic product ineffective Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CLONAZEPAM. However, 38 reports have been filed with the FAERS database.

What Other Side Effects Does CLONAZEPAM Cause?

Drug ineffective (5,088) Toxicity to various agents (4,028) Completed suicide (3,320) Drug abuse (3,287) Off label use (2,590) Anxiety (2,376) Somnolence (2,260) Dyspnoea (1,987) Depression (1,838) Insomnia (1,836)

What Other Drugs Cause Therapeutic product ineffective?

ALBUTEROL (379) METHYLPHENIDATE (135) METHOTREXATE (133) ESTRADIOL\NORETHINDRONE (132) ESTRADIOL (124) SECUKINUMAB (111) CLOBETASOL (59) PREDNISONE (59) TRIAMCINOLONE (51) BUPRENORPHINE\NALOXONE (44)

Which CLONAZEPAM Alternatives Have Lower Therapeutic product ineffective Risk?

CLONAZEPAM vs CLONIDINE CLONAZEPAM vs CLOPIDOGREL CLONAZEPAM vs CLOPIDOGREL BESILATE CLONAZEPAM vs CLOPIDOGREL BISULFATE CLONAZEPAM vs CLORAZEPATE

Related Pages

CLONAZEPAM Full Profile All Therapeutic product ineffective Reports All Drugs Causing Therapeutic product ineffective CLONAZEPAM Demographics